MedPath

Comparative Effectiveness Feasibility Trial for Insomnia Among Breast Cancer Survivors

Not Applicable
Completed
Conditions
Breast Cancer Female
Insomnia
Interventions
Behavioral: Mindfulness-Based Therapy
Behavioral: Cognitive Behavioral Therapy for Insomnia
Registration Number
NCT03328169
Lead Sponsor
George Washington University
Brief Summary

Women with breast cancer who report insomnia that started or worsened during breast cancer diagnosis and treatment will be enrolled in a group behavioral trial to one of two arms testing cognitive behavioral therapy for insomnia against a mindfulness-based therapy.

Detailed Description

The investigators are recruiting breast cancer survivors with stage I-III or Eastern Cooperative Oncology Group 0-1 breast cancer to enroll in a group-delivered behavioral trial for insomnia. The investigators are comparing mindfulness-based therapies delivered in an alternative medicine context to cognitive behavioral therapy for insomnia. The intervention is 9 weeks, for two hours weekly.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
26
Inclusion Criteria
  • American Joint Committee on Cancer (AJCC) Stage I-III or Eastern Cooperative Oncology Group (ECOG) 0-1 breast cancer
  • completed active treatment (surgery, radiation, chemotherapy) at least three months prior
  • within 5 years of treatment or still on adjuvant therapy
  • Completes informed consent to participate
Exclusion Criteria
  • sleep apnea or restless leg syndrome
  • practicing mindfulness techniques >1/wk

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MindfulnessMindfulness-Based TherapyMindfulness-Based Therapy
CBT-ICognitive Behavioral Therapy for InsomniaCognitive Behavioral Therapy for Insomnia
Primary Outcome Measures
NameTimeMethod
Change in InsomniaNine weeks

Measured using the Pittsburgh Sleep Quality Index (Scale 0-21; higher scores are worse)

Secondary Outcome Measures
NameTimeMethod
Change in cognitive functionNine weeks

Measured via the Montreal Cognitive Assessment (MOCA)

Change in FatigueNine weeks

Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue (Scale 8-40; higher is worse)

Change in InsomniaNine weeks

Measured using an actigraph

Trial Locations

Locations (1)

GW Center for Integrative Medicine

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath